Uses
1.5% Glycine Irrigation USP is indicated as an irrigant during transurethral prostatic or bladder surgery.
Source: US FDA prescribing information
Molecule
Glycine is a prescription medicine indicated as an irrigant during transurethral prostatic or bladder surgery. It is available as irrigation solution. MedsAcross supplies Glycine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
1.5% Glycine Irrigation USP is indicated as an irrigant during transurethral prostatic or bladder surgery.
Source: US FDA prescribing information
As required for irrigation. 1.5% Glycine Irrigation USP should be administered only by the appropriate transurethral urologic instrumentation. It has been reported that absorption is significantly increased if the container is higher than 60 cm (24 inches) above the patient. This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Source: US FDA prescribing information
1.5% Glycine Irrigation USP is not for injection. It is contraindicated in patients with anuria.
Source: US FDA prescribing information
Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction. The amount of fluid absorbed during a transurethral resection is a function of the volume and hydrostatic pressure of the irrigant used, the number and size of venous sinuses opened, and the duration of the procedure. Since irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes, any irrigation solution must be regarded as a systemic drug. Absorption of large amounts of fluids containing glycine and the resultant osmotic diuresis may significantly affect cardiopulmonary and renal dynamics. Absorption of large amounts of irrigating solution can also result in pronounced hyponatremia and water intoxication.
Source: US FDA prescribing information
Adverse reactions may include fluid and electrolyte disorders such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema and dehydration, cardiovascular/pulmonary disorders such as pulmonary congestion, hypotension, tachycardia, angina-like pain and thrombophlebitis, other possible reactions include visual disturbances, convulsions, nausea, vomiting, diarrhea, vertigo and urticaria. Literature includes reports on hyponatremia, hyperammonemia, transient blindness, coma (immediate or delayed), and digitalis toxicity in digitalized patients. If an adverse reaction occurs, discontinue the irrigant and reevaluate the clinical status of the patient.
Source: US FDA prescribing information
Protect from freezing. It is recommended that the product be stored at room temperature (25°C), however, brief exposure up to 40°C does not adversely affect the product. Do not warm container over 150°F (66°C).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Glycine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Glycine 1.5 g/100 mL irrigation solutionIrrigationGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 25 May 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Glycine in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 1 presentations of Glycine and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Glycine on 25 May 1976, according to Drugs@FDA.
No listed presentation of Glycine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Glycine is classified under ATC code B05CX03 (Glycine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.